Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript
Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.39.
Pulmonx Corp (LUNG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 1,546,089 | $19,712,635 | -48% | 0.04% |
| 2. | Divisadero Street Capital William Zolezzi | 1,406,993 | $17,939,161 | 4.05% | |
| 3. | Millennium Management Israel Englander | 804,023 | $10,251,293 | +114% | 0% |
| 4. | Braidwell LP Alex Karnal | 787,954 | $10,046,414 | -21% | 0.36% |
| 5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 652,400 | $8,318,100 | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.51 | 1,700 | Director | 11,910 | 2022-11-29 | Filing | |
| $5.29 | 100 | Director | 30,035 | 2022-11-08 | Filing | |
| $5.31 | 5,338 | Director | 29,935 | 2022-11-08 | Filing | |
| $40.00 | 2,500 | Director | 7,532 | 2021-07-12 | Filing | |
| $44.12 | 2,222 | Director | 5,032 | 2021-06-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.36 | 1,184 | 307,868 | 2024-03-22 | Filing | ||
| $9.06 | 1,916 | 239,952 | 2024-03-01 | Filing | ||
| $9.06 | 753 | 241,868 | 2024-03-01 | Filing | ||
| $9.06 | 428 | 242,621 | 2024-03-01 | Filing | ||
| $9.06 | 669 | 47,410 | 2024-03-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,646,451 | $71,992,250 | 0.05% | |
| 2. | 3,309,501 | $42,196,138 | 0% | |
| 3. | 3,117,063 | $39,742,553 | 0% | |
| 4. | 2,278,721 | $29,053,700 | 0% | |
| 5. | 2,066,442 | $26,347,136 | 0% |
News See All
Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Pulmonx Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Pulmonx Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Pulmonx Corporation (NASDAQ:LUNG) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Pulmonx First Quarter 2023 Earnings Conference Call. As a reminder, today’s conference is being recorded.
Pulmonx Corporation (NASDAQ:LUNG) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Pulmonx Q4 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Bill Ackman, Crispin Odey, Citadel LLC, Point72 Asset Management, Hyzon Motors Inc. (HYZN), Culp, Inc. (CULP), and More
Pershing Square Capital CEO Bill Ackman broke a three-year winning streak in 2022, posting his first down year since 2018.
Analysts Just Trimmed Their Price Targets of These 10 Stocks
In this article, we will take a look at the 10 stocks that recently received price-target cuts from analysts.
Hedge Funds Are Buying Pulmonx Corporation (LUNG)
In this article we will check out the progression of hedge fund sentiment towards Pulmonx Corporation (NASDAQ:LUNG) and determine whether it is a good investment right now.
10 Pharmaceutical Stocks to Buy According to Efrem Kamen's Pura Vida Investments
In this article, we examined Efrem Kamen's portfolio management strategy and approach to investing in pharmaceutical stocks.
Is Pulmonx Corporation (LUNG) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S.
Billionaire Hedge Funds
